Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 4025-4030

  Kousidou, O Ch ^a   Roussidis, A E ^a   Theocharis, A D ^a   Karamanos, N K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Breast cancer; Cell growth; Genistein; Invasion; MMPs; TIMPs

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MEMBRANE TYPE 2 MATRIX METALLOPROTEINASE; MEMBRANE TYPE 3 MATRIX METALLOPROTEINASE; MESSENGER RNA; METALLOPROTEINASE; STROMELYSIN; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG; ISOENZYME; MATRIX METALLOPROTEINASE;

ARTICLE; BREAST CANCER; BREAST CELL; BREAST METASTASIS; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL CULTURE; EPITHELIUM CELL; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MMP 1 GENE; MMP 7 GENE; MMP 9 GENE; MMP GENE; MT2 MMP GENE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TIMP 1 GENE; TIMP GENE; BIOSYNTHESIS; BREAST TUMOR; ENZYMOLOGY; GENETICS; MAMMARY GLAND; PATHOLOGY; PHYSIOLOGY;

BREAST NEOPLASMS; HUMANS; ISOENZYMES; MAMMARY GLANDS, HUMAN; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED;

EID: 14944361909     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
2. Honig S: Treatment of metastatic diseases: Hormonal therapy and chemotherapy. In: Harris J, Lippman M, Morrow M, Hellman S (eds). Diseases of the Breast, 669-734, 1996.
3. Nabeshima K, Inoue T, Shimao Y and Sameshima T: Matrix metalloproteinases in tumor invasion: Role for cell migration. Pathol Int 52: 255, 2002.
4. Nagase H and Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
5. Duffy MJ: The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 10: 125-155, 1992.
6. Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S and Pozzatti RO: Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res 52: 4942-4947, 1992.
7. Woessner JF: The matrix metalloproteinase family. In: Parks WC, Mecham RP (eds). Matrix Metalloproteinases, 1-14, 1998.
8. Murray GI: Matrix metalloproteinases: a multifunctional group of molecules. J Pathol 195: 135-137, 2001.
9. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinase in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997.
10. Westermarck J and Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
11. Yana I and Seiki M: MT-MMPs play pivotal roles in cancer dissemination. Clin Exp Metastasis 19: 209-215, 2002.
12. Bachmeier BE, Nerlich AG, Lichtinghagen R and Sommerhoff CP: Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 21: 3821-3828, 2001.
13. Bartsch JE, Staren ED and Appert HE: Matrix metalloproteinase expression in breast cancer. J Surg Res 110: 383-392, 2003.
14. Benaud C, Dickson RB and Thompson EW: Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Res Treat 50: 97-116, 1998.
15. Kleiner DE and Stetler-Stevenson W: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43: S42-S51, 1999.
16. Grignon DJ et al: High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 56: 1654-1659, 1996.
17. Liu XW, Bernardo MM, Fridman R and Kim HR: Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem 278: 40364-40372, 2003.
18. Tzanakakis GN, Hjerpe A and Karamanos NK: Proteoglycan synthesis induced by transforming and basic fibroblasts growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway. Biochimie 79: 323-332, 1997.
19. Syrokou A, Tzanakakis GN, Hjerpe A and Karamanos NK: Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity. Biochimie 81: 733-744, 1999.
20. Nikitovic D, Tsatsakis AM, Karamanos NK and Tzanakakis GN: The effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by two osteosarcoma cell lines depends on tyrosine kinase and the estrogen receptor density. Anticancer Res 23: 459-64, 2003.
21. Mitropoulou TN, Tzanakakis GN, Nikitovic D, Tsatsakis A and Karamanos NK: In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans / proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells. Anticancer Res 22: 2841-2846, 2002.
22. Stetler-Stevenson WG: Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 148: 1345-1350, 1996.
23. Hagedorn H, Bachmeier BE and Nerlich AG: Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-β in invasive carcinomas. Int J Oncol 18: 669-681, 2001.
24. Reddy KB, Krueger JS, Kondapaka SB and Diglio CA: Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer 82: 268-73, 1999.
25. Liu JF, Crepin M, Liu JM, Barritault D and Ledoux D: FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 293: 1174-1182, 2002.
26. Nutt JE and Lunec J: Induction of metalloproteinase (MMP-1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells. Eur J Cancer 32: 2127-2135, 1996.
27. Brown PD: Matrix metalloproteinase inhibitors. Breast Cancer Res Treat 52: 125-136, 1998.
28. McCarthy K, Maguire T, McGreal G, McDermott E, O' Higgins N and Duffy MJ: High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer. Int J Cancer 84: 44-48, 1999.
29. Brew K, Dinakarpandian D and Nagase H: Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477: 267-283, 2000.
30. Hurst DR, Li H, Xu X, Badisa VL, Shi YE and Sang QX: Development and characterization of a new polyclonal antibody specifically against tissue inhibitor of metalloproteinases 4 in human breast cancer. Biochem Biophys Res Commun 281: 166-171, 2001.